Startups
Viral vector CDMO delivering AAV, lentiviral and retroviral vector manufacturing for cell and gene therapy developers from preclinical to GMP supply.
Overview
Location
United States, Indiana, Indianapolis
Employees
51-200
Total raised
$18.5M
Founded date
2014
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 1, 2024 | Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA | Strategic acquisition will enable Genezen to deliver late-phase and commercial gene therapy development and manufacturing services to customers around the world. BOSTON and INDIANAPOLIS, July 1, 2024 /PRNewswire/ -- Genezen, a best-in-class... |
| Mar 28, 2024 | Advancements in Biotechnology: Navigating the Future of Genetic Medicine | The realm of biotechnology stands at the precipice of a new era, marked by groundbreaking advancements that promise to redefine the landscape of genetic medicine. As we delve deeper into the complexities of the human genome, the potential f... |
| Nov 2, 2023 | Genezen Raises $18.5M in Growth Equity Funding | Genezen, a Fishers, IN-based cell and gene therapy contract development and manufacturing organization (CDMO), raised $18.5M in Growth Equity funding. The round was led by Ampersand Capital Partners. The company intends to use the funds to ... |
| Genezen | “Genezen is a US-based viral vector CDMO specializing in GMP viral vector manufacturing, viral vector development, cell manufacturing & testing” |
Reviews 0
FAQ about Genezen
When was Genezen founded?
Genezen was founded in 2014.
How much funding has Genezen raised?
Genezen has raised $18.5M in total across 1 funding round.
What has the press written about Genezen?
Parsers VC has collected 5 articles mentioning Genezen, among them “Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA” (Jul 1, 2024) and “Advancements in Biotechnology: Navigating the Future of Genetic Medicine” (Mar 28, 2024).
Is Genezen still active?
Yes, Genezen is active; its latest activity on Parsers VC dates from May 5, 2025.